Dihydroartemisinin attenuates pulmonary inflammation and fibrosis in rats by suppressing JAK2/STAT3 signaling

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has induced a worldwide pandemic since early 2020. COVID-19 causes pulmonary inflammation, secondary pulmonary fibrosis (PF); however, there are still no effective treatments for PF. The present study aimed to explore the inhibitory effect o...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Xiaolan, Jiang, Xingyu, Zhang, Chuanmeng, Jiang, Kejia, Zhao, Xiaojun, Guo, Ting, Zhu, Xiaowei, Bao, Jingjing, Dou, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876897/
https://www.ncbi.nlm.nih.gov/pubmed/35120332
http://dx.doi.org/10.18632/aging.203874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876897/
https://www.ncbi.nlm.nih.gov/pubmed/35120332
http://dx.doi.org/10.18632/aging.203874

Ejemplares similares